Cervical Cancer Prevention Week: 2023

11k
Total downloads
26k
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 28 Jun 2023

A novel DNA damage repair-related gene signature predicting survival, immune infiltration and drug sensitivity in cervical cancer based on single cell sequencing

Xiaoqing Xiang
Jiawen Kang
Jingwen Jiang
Yaning Zhang
Yong Zhang
Lesai Li
Xiaoning Peng

A novel DNA damage repair-related gene signature predicting survival, immune infiltration and drug sensitivity in cervical cancer based on single cell sequencing

doi 10.3389/fimmu.2023.1198391

3,896 views
1 citation

CLINICAL TRIAL

Published on 21 Apr 2023

Efficacy and safety of serplulimab plus nab-paclitaxel in previously treated patients with PD-L1–positive advanced cervical cancer: a phase II, single-arm study

Jusheng An
Xiumin Li
Jing Wang
Lijing Zhu
Ruifang An
Kui Jiang
Yi Huang
Ke Wang
Guiling Li
7 more
Lingying Wu

Efficacy and safety of serplulimab plus nab-paclitaxel in previously treated patients with PD-L1–positive advanced cervical cancer: a phase II, single-arm study

doi 10.3389/fimmu.2023.1142256

3,415 views
7 citations

ORIGINAL RESEARCH

Published on 18 Jul 2022

A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes

Hui-Hui Xu
Hui-Li Wang
Tong-Jin Xing
Xue-Quan Wang

A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes

doi 10.3389/fimmu.2022.851622

3,501 views
14 citations

ORIGINAL RESEARCH

Published on 29 Apr 2022

m6A Regulator-Mediated Tumour Infiltration and Methylation Modification in Cervical Cancer Microenvironment

Wenyi Zhang
Pei Xiao
Jiayi Tang
Rui Wang
Xiangdong Wang
Fengxu Wang
Junpu Ruan
Shali Yu
Juan Tang
1 more
Xinyuan Zhao

m6A Regulator-Mediated Tumour Infiltration and Methylation Modification in Cervical Cancer Microenvironment

doi 10.3389/fimmu.2022.888650

3,527 views
24 citations

ORIGINAL RESEARCH

Published on 03 Sep 2021

Development of a Novel Immune Infiltration-Based Gene Signature to Predict Prognosis and Immunotherapy Response of Patients With Cervical Cancer

Sihui Yu
Xi Li
Jiawen Zhang
Sufang Wu

Development of a Novel Immune Infiltration-Based Gene Signature to Predict Prognosis and Immunotherapy Response of Patients With Cervical Cancer

doi 10.3389/fimmu.2021.709493

5,381 views
22 citations

Share on

Frontiers in Immunology

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- 3.5 impact factor
- 6.2 citescore

Impact

26kTopic views
14kArticle views
11kArticle downloads